Viewing Study NCT07022834


Ignite Creation Date: 2025-12-25 @ 2:22 AM
Ignite Modification Date: 2025-12-27 @ 10:00 AM
Study NCT ID: NCT07022834
Status: RECRUITING
Last Update Posted: 2025-06-15
First Post: 2025-06-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Real-world Study of Darafenib or Trametinib and Clofarabine for High-risk/Recurrent/Refractory Langerhans Cell Histiocytosis in Children
Sponsor: West China Second University Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module